Global Journal of Medical Research, F: Diseases, Volume 22 Issue 6

Intradermal Glucose 5% Injections for Mild Localized Neuropathic Pain- A New Approach to Reduce Pain Medication 6 Year 2022 Global Journal of Medical Research Volume XXII Issue VI Version I ( D ) F © 2022 Global Journals xliii Tavee J. Nerve conduction studies: Basic concepts. Handb Clin Neurol. 2019; 160:217-224. doi: 10.1016/B978-0-444- 64032-1.00014-X. PMID: 31277849. xliv Dubin AE, Pata poutian A. Nociceptors: the sensors of the pain pathway. J Clin Invest. 2010 Nov;120(11):3760-72. doi: 10.1172/JCI42843. Epub 2010 Nov 1. PMID: 21041958; PMCID: PMC2964977. xlv Filtjens J, Roger A, Quatrini L, Wieduwild E, Gouilly J, Hoeffel G, Rossignol R, Daher C, Debroas G, Henri S, Jones CM, Malissen B, Mackay LK, Moqrich A, Carbone FR, Ugolini S. Nociceptive sensory neurons promote CD8 T cell responses to HSV-1 infection. Nat Commun. 2021 May 18;12(1):2936. doi: 10.1038/s41467-021-22841-6. PMID: 34006861; PMCID: PMC8131384. xlvi Maglie R, Souza Monteiro de Araujo D, Antiga E, Geppetti P, Nassini R, De Logu F. The Role of TRPA1 in Skin Physiology and Pathology. Int J Mol Sci. 2021 Mar 17;22(6):3065. doi: 10.3390/ijms22063065. PMID: 33802836; PMCID: PMC8002674. xlvii Wu D, Lee S, Luo J, Xia H, Gushchina S, Richardson PM, Yeh J, Krügel U, Franke H, Zhang Y, Bo X. Intraneural Injection of ATP Stimulates Regeneration of Primary Sensory Axons in the Spinal Cord. J Neurosci. 2018 Feb 7;38(6):1351-1365. xlviii Moriyama M, Kitamura A, Ikezaki H, Nakanishi K, Kim C, Sakamoto A, Ogawa R. Systemic ATP infusion improves spontaneous pain and tactile allodynia, but not tactile hypesthesia, in patients with postherpetic neuralgia. J Anesth. 2004;18(3):177-80. doi: 10.1007/s00540-004-0240-x. PMID: 15290415. xlix Hayashida M, Fukuda K, Fukunaga A, Meno A, Sato K, Tarui K, Arita H, Kaneko Y, Hanaoka K. Analgesic effect of intravenous ATP on postherpetic neuralgia in comparison with responses to intravenous ketamine and lidocaine. J Anesth. 2005;19(1):31-5. doi: 10.1007/s00540-004-0273-1. PMID: 15674513. l Fukuda K, Hayashida M, Fukunaga A, Kasahara M, Koukita Y, Ichinohe T, Kaneko Y. Pain-relieving effects of intravenous ATP in chronic intractable orofacial pain: an open-label study. J Anesth. 2007;21(1):24-30. doi: 10.1007/s00540-006-0444-3. Epub 2007 Jan 30. PMID: 17285409. li Sawynok J. Adenosine and ATP receptors. HandbExpPharmacol. 2007;(177) : 309-28 doi :10.1007/978-3- 540-33823-9_11. PMID 17087128. lii Lyftogt J. Prolotherapy and Achilles tendinopathy: a prospective pilotstudy of an old treatment. AustralasMusculoskel Med. 2005; 10:16-19. liii Köroğlu O, Örsçelik A, Karasimav O, Demir Y, Solmaz I, Is 5% dextrose prolotherapy effective for radicular low back pain? Gulhane Medical Journal 2019; 61 (3): 123-127. liv Lyftogt, J, Subcutaneous prolotherapy treatment of refractory knee, shoulder, and lateral elbow pain. Australasian Musculoskel Med. 2007; 12 (1), 107-109 lv Amanollahi A., Asheghan M., Hashemi S, Subacromial corticosteroid injection versus subcutaneous 5% dextrose in patients with chronic rotator cuff tendinopathy: A short-term randomized clinical trial, Interventional Medicine and Applied Science IMAS 2020, 11 (3), 154-160 lvi Kersschot J, Management of Lateral Elbow Pain with Glucopuncture. Global Journal of Orthopedics Research 3(1): 2021 lvii Reeves KD, Sit RW, Rabago DP. Dextrose Prolotherapy: A Narrative Review of Basic Science, Clinical Research, and Best Treatment Recommendations. Phys Med Rehabil Clin N Am. 2016 Nov;27(4):783-823. doi: 10.1016/j.pmr.2016.06.001. PMID: 27788902 lviii Distel LM, Best TM. Prolotherapy: a clinical review of its role in treating chronic musculoskeletal pain. PM R. 2011 Jun;3(6 Suppl 1): S78-81. doi: 10.1016/j.pmrj.2011.04.003. PMID: 21703585. lix Ganji R. Dextrose prolotherapy for improvement of rotator cuff lesions: ready for clinical use? Hong Kong Med J. 2018;24(4):429–430. doi:10.12809/hkmj187480 lx Bae G, Kim S, Lee S, Lee WY, Lim Y. Prolotherapy for the patients with chronic musculoskeletal pain: systematic review and meta-analysis. Anesthesia and Pain Medicine. 2020 lxi Panagos A. Dextrose Prolotherapy to Treat Pain, Improve Activities of Daily Living, and Improve Quality of Life in an Ewing's Sarcoma Patient Following Radiation and Chemotherapy Treatment. Cureus. 2021 Feb 25;13(2): e13549. doi: 10.7759/cureus.13549. PMID: 33791172; PMCID: PMC8000706. lxii Asheghan M, Hashemi SE, Hollisaz MT, Roumizade P, Hosseini SM, Ghanjal A. Dextrose prolotherapy versus radial extracorporeal shock wave therapy in the treatment of chronic plantar fasciitis: A randomized, controlled clinical trial. Foot Ankle Surg. 2021 Aug;27(6):643-649. doi: 10.1016/j.fas.2020.08.008. Epub 2020 Aug 25. PMID: 32919897. lxiii Wang J, Liang J, Yao J, Song HX, Yang XT, Wu FC, Ye Y, Li JH, Wu T. Meta-analysis of clinical trials focusing on hypertonic dextrose prolotherapy (HDP) for knee osteoarthritis. Aging Clin Exp Res. 2021 Aug 27. doi: 10.1007/s40520-021-01963-3. Epub ahead of print. PMID: 34449061. lxiv Nair A. Prolotherapy as an intervention for chronic, refractory musculoskeletal pain. Saudi J Anaesth. 2021 Oct- Dec;15(4):463-465. doi: 10.4103/sja.sja_374_21. Epub 2021 Sep 2. PMID: 34658744; PMCID: PMC8477775. lxv Ekwueme EC, Mohiuddin M, Yarborough JA, Brolinson PG, Docheva D, Fernandes HAM, et al. Prolotherapy induces an inflammatory response in human tenocytes in vitro. Clin OrthopRelat Res. 2017;475(8):2117–27